(Press-News.org) Cavities at protein-protein interaction interfaces are often considered "undruggable" because their shallow or large geometries hinder the stable binding by small molecules. A study published in Journal of the American Chemical Society and led by Prof. LI Yang from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences elucidated the molecular mechanisms governing nanoparticles (NPs) recognition and selective targeting of protein surface cavities.
Using SARS-CoV-2 S trimer (S trimer) as a model system, researchers compared CeO2NPs and gold nanoparticles (AuNPs) to evaluate the role of surface chemistry in protein cavity targeting, which have comparable sizes but different surface chemistries. They found that both NPs interacted with the S trimer and exhibited antiviral effects, but differed in their preferred binding sites and molecular mechanisms.
In detail, CeO2NPs bound to the central cavity enriched in aspartic acid (Asp) residues where coordination with Asp carboxyl groups enabled stable binding and interfered with ACE2 receptor recognition. In contrast, AuNPs predominantly bound to arginine (Arg)-rich lateral cavities near the S1/S2 cleavage region through electrostatic interactions and hydrogen bonding, thereby interfering with host protease-mediated activation of the S trimer.
Furthermore, researchers showed that NP targeting of protein cavities could not be explained by geometric accessibility alone. Instead, the selectivity depended on how NP surface chemistry matched the local amino acid environment within a cavity. Precise cavity recognition therefore required both geometric compatibility and surface chemical interactions.
The findings of this study improve the understanding of how NPs selectively bind to protein surface cavities, and provide guidance for the rational design of NPs to modulate protein function.
END
Amino acid residue-driven nanoparticle targeting of protein cavities beyond size complementarity
2026-03-02
ELSE PRESS RELEASES FROM THIS DATE:
New AI algorithm enables scientific monitoring of "blue tears"
2026-03-02
In recent years, "blue tears" chasing has become a popular tourism activity along coasts to witness the spectacular natural phenomenon. However, the occurrence and movement of algal blooms are unpredictable, which impacts the quality of tourist experiences while posing safety risks and ecological pressures.
In a study published in Ecological Informatics, a team led by Prof. LI Jianping from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, along with the collaborators from the Ministry of Natural Resources, developed an innovative real-time video ...
Insufficient sleep among US adolescents across behavioral risk groups
2026-03-02
About The Study: The findings of this study show a broad increase in insufficient sleep across all demographic groups, driven largely by increasing reports of very short sleep (5 hours or less). Notably, insufficient sleep increased as much or more among students without behavioral risks, suggesting that structural and environmental factors affecting most adolescents, rather than specific behaviors such as electronic media use, substance use, or sedentary activity, are contributing to wide spread sleep loss. These trends highlight the need for population-level rather than targeted interventions.
Corresponding Author: To contact the corresponding ...
Long COVID and recovery among US adults
2026-03-02
About The Study: In 2024, 8.3% of U.S. adults—an estimated 21.3 million—reported ever having long COVID (LC), among whom nearly 6 in 10 reported recovery, consistent with RECOVER initiative findings showing similar LC prevalence in 2023 and 2024 and longitudinal Veterans Affairs data demonstrating declining LC prevalence. Yet many adults, particularly those 35 years or older, continue to experience lasting symptoms. With no LC treatment demonstrating clear efficacy, greater investment in understanding biological mechanisms, including immunotypic differences between those who recover and those who do not, may provide insights ...
Trends in poverty and birth outcomes in the US
2026-03-02
About The Study: This study found stark disparities in birth outcomes by poverty status, with inequities growing for low birth weight in recent years. These disparities point to the need for more support during pregnancy and birth for low-income families. Antipoverty policies can provide needed resources to promote better maternal and child health, although the availability and generosity of these programs vary across states.
Corresponding Author: To contact the corresponding author, Emily C. Dore, PhD, MPH, MSW, email edore@hsph.harvard.edu.
To ...
Heterogeneity of treatment effects of GLP-1 RAs for weight loss in adults
2026-03-02
About The Study: In this systematic review and meta-analysis, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) produced greater weight loss among women than men; however, their efficacy was consistent across other important subpopulations. These findings may inform clinical decision-making.
Corresponding Author: To contact the corresponding author, G. Caleb Alexander, MD, MS, email galexan9@jhmi.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2025.8222)
Editor’s ...
Within-person association between daily screen use and sleep in youth
2026-03-02
About The Study: Per the results of this systematic review and meta-analysis, daily screen time has a small but significant within-person correlation with later sleep onset; however, short-term daily fluctuations in screen time appear to have minimal impact on sleep duration, efficiency, or quality. Screen time may delay bedtime but is not inherently detrimental to other aspects of sleep health in youth, contrasting with between-person studies showing stronger adverse associations.
Corresponding Author: To contact the corresponding author, Matthew Bourke, PhD, email matthew.bourke1@deakin.edu.au.
To access the embargoed study: Visit ...
Low-dose lithium for mild cognitive impairment
2026-03-02
About The Study: This pilot randomized clinical trial established feasibility, confirmed safety and tolerability, and generated effect size estimates for future trials of low-dose lithium in mild cognitive impairment. None of the coprimary outcomes met the prespecified significance threshold.
Corresponding Author: To contact the corresponding author, Ariel G. Gildengers, MD, email ariel.gildengers@pitt.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2026.0072)
Editor’s Note: Please see ...
Catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation
2026-03-02
About The Study: In patients with atrial fibrillation and a recent stroke history, standard therapy plus catheter ablation did not significantly reduce the risk of the primary composite end point. The observed event rate was lower than anticipated, suggesting that the study was underpowered to detect clinically meaningful differences.
Corresponding Author: To contact the corresponding author, Kazumi Kimura, MD, PhD, email k-kimura@nms.ac.jp.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2026.0155)
Editor’s Note: Please see ...
A new theory of brain development
2026-03-02
Your brain begins as a single cell. When all is said and done, it will house an incredibly complex and powerful network of some 170 billion cells. How does it organize itself along the way? Cold Spring Harbor Laboratory neuroscientists have come up with a surprisingly simple answer that could have far-reaching implications for biology and artificial intelligence.
Stan Kerstjens, a postdoc in Professor Anthony Zador’s lab, frames the question in terms of positional information. “The ...
Pilot clinical trial suggests low dose lithium may slow verbal memory decline
2026-03-02
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.
An exploratory clinical trial from the University of Pittsburgh suggests that low‑dose oral lithium may help slow the decline of verbal memory, or ability to remember and recall words and sentences, in older adults with mild cognitive impairment, particularly among those with evidence of amyloid beta—one of the hallmark biomarkers of Alzheimer’s disease.
The study, ...